ATE532793T1 - Verfahren zur herstellung von molekülen mit verminderter immunogenität - Google Patents

Verfahren zur herstellung von molekülen mit verminderter immunogenität

Info

Publication number
ATE532793T1
ATE532793T1 AT04809479T AT04809479T ATE532793T1 AT E532793 T1 ATE532793 T1 AT E532793T1 AT 04809479 T AT04809479 T AT 04809479T AT 04809479 T AT04809479 T AT 04809479T AT E532793 T1 ATE532793 T1 AT E532793T1
Authority
AT
Austria
Prior art keywords
protein
peptide
reduced immunogenicity
producing molecules
cross
Prior art date
Application number
AT04809479T
Other languages
English (en)
Inventor
Christopher Marshall
Original Assignee
Avatar Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avatar Biotechnologies Inc filed Critical Avatar Biotechnologies Inc
Application granted granted Critical
Publication of ATE532793T1 publication Critical patent/ATE532793T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04809479T 2003-07-03 2004-07-06 Verfahren zur herstellung von molekülen mit verminderter immunogenität ATE532793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48488003P 2003-07-03 2003-07-03
PCT/US2004/021859 WO2005051975A2 (en) 2003-07-03 2004-07-06 Methods for obtaining molecules with reduced immunogenicity

Publications (1)

Publication Number Publication Date
ATE532793T1 true ATE532793T1 (de) 2011-11-15

Family

ID=34632731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809479T ATE532793T1 (de) 2003-07-03 2004-07-06 Verfahren zur herstellung von molekülen mit verminderter immunogenität

Country Status (7)

Country Link
US (1) US20050054572A1 (de)
EP (1) EP1641813B1 (de)
JP (1) JP5009614B2 (de)
AT (1) ATE532793T1 (de)
AU (2) AU2004293371A1 (de)
CA (1) CA2530756C (de)
WO (1) WO2005051975A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007307206B2 (en) 2006-10-04 2016-02-11 Janssen Pharmaceutica, N.V. Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
EP2701743A4 (de) 2011-04-27 2015-08-19 Univ Northwestern Für pathologische tau-dimere und präfibrilläre pathologische tau-oligomere selektive antikörper und ihre verwendungen bei der anwendung, diagnose und überwachung von tauopathien
US20130302366A1 (en) * 2012-05-09 2013-11-14 Christopher Marshall Conformationally Specific Viral Immunogens
EP3024483B1 (de) 2013-07-25 2020-01-15 Calder Biosciences Inc. Konformationsstabilisierte rsv-f-präfusionsproteine
EP3395826B1 (de) 2013-08-03 2020-10-14 Calder Biosciences Inc. Verfahren zur herstellung und verwendung von influenza virus hämagglutinin komplexen
JP2020532953A (ja) 2017-08-07 2020-11-19 カルダー・バイオサイエンシズ・インコーポレイテッド コンフォメーションが安定化されたｒｓｖ融合前ｆタンパク質
EP3806888B1 (de) 2018-06-12 2024-01-31 Obsidian Therapeutics, Inc. Von pde5 abgeleitete regulatorische konstrukte und verfahren zur verwendung in der immuntherapie
EP3870600A1 (de) 2018-10-24 2021-09-01 Obsidian Therapeutics, Inc. Er-abstimmbare proteinregulierung
AU2020235865A1 (en) 2019-03-08 2021-09-23 Obsidian Therapeutics, Inc. Human carbonic anhydrase 2 compositions and methods for tunable regulation
US20220267398A1 (en) 2019-06-12 2022-08-25 Obsidian Therapeutics, Inc. Ca2 compositions and methods for tunable regulation
AU2020290522A1 (en) 2019-06-12 2022-01-20 Obsidian Therapeutics, Inc. CA2 compositions and methods for tunable regulation
WO2021046451A1 (en) 2019-09-06 2021-03-11 Obsidian Therapeutics, Inc. Compositions and methods for dhfr tunable protein regulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747654A (en) * 1993-06-14 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Recombinant disulfide-stabilized polypeptide fragments having binding specificity
US6410022B1 (en) * 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
DE69833755T2 (de) * 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
ES2367475T3 (es) * 1999-10-15 2011-11-03 Avatar Medical, L.L.C. Proteínas estabilizadas.
CA2440474A1 (en) * 2001-04-05 2002-10-17 Virginia Mason Research Center Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment

Also Published As

Publication number Publication date
AU2004293371A1 (en) 2005-06-09
WO2005051975A3 (en) 2005-12-29
CA2530756C (en) 2012-10-16
JP5009614B2 (ja) 2012-08-22
EP1641813A2 (de) 2006-04-05
CA2530756A1 (en) 2005-06-09
WO2005051975A2 (en) 2005-06-09
EP1641813B1 (de) 2011-11-09
JP2007537133A (ja) 2007-12-20
US20050054572A1 (en) 2005-03-10
AU2011200649A1 (en) 2011-03-10
EP1641813A4 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE532793T1 (de) Verfahren zur herstellung von molekülen mit verminderter immunogenität
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DE602005022387D1 (de) Verfahren zur Herstellung von Dipeptiden
WO2005021592A3 (en) Enhancing the circulating half-life of interleukin-2 proteins
DE602005021485D1 (de) Verfahren und zusammensetzungen mit molkeproteinisolaten
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
NO20062087L (no) Bispesifikt antistoff som substituerer for funksjonelle proteiner
DK1534830T3 (da) In vito-peptid-ekspressionsbibliotek
DE60332024D1 (de) Verfahren zur herstellung von soja protein
ATE334998T1 (de) Verfahren zur herstellung cyclischer peptide
DE60335726D1 (de) Chromoprotein und fluoroproteine
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
DE60125218D1 (de) Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
WO2003050283A3 (en) A structure for presenting desired peptide sequences
ATE365801T1 (de) Modulierung durch il-tif/interleukin-21
IL173954A0 (en) Libraries of recombinant chimeric proteins and methods of generating the same
WO2004108749A3 (en) Binding peptides: methods for their generation and use
DE69734586D1 (de) Retinoid-metabolisierendes protein
ATE531724T1 (de) Verfahren zur herstellung von peptiden
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
ATE481641T1 (de) Verfahren zur fixierung eines proteins auf einem pyrrolpolymerisat, und dessen verwendung zur herstellung eines sensors